目录
REVIEW
MINIREVIEWS
- Second-line treatment of advanced hepatocellular carcinoma:Time for more individualized treatment options?
- Metabolic-associated fatty liver disease from childhood to adulthood:State of art and future directions
- Liver dysfunction during COVID-19 pandemic:Contributing role of associated factors in disease progression and severity
- Understanding fatigue in primary biliary cholangitis:From pathophysiology to treatment perspectives
- Fibrosis regression following hepatitis C antiviral therapy
ORIGINAL ARTICLE
- COVID-19 liver and gastroenterology findings:An in silico analysis of SARS-CoV-2 interactions with liver molecules
- Clinical outcomes of coronavirus disease 2019 in liver transplant recipients
- Intensive care unit readmission in adult Egyptian patients undergoing living donor liver transplant:A single-centre retrospective cohort study
- Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization
- Relationship between phase angle,steatosis,and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus
- DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation
- Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
- Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
- Gut dysbiosis and body composition in cirrhosis
- Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
SYSTEMATIC REVIEWS
META-ANALYSIS